HAEMORRHAGIC PANCREATIC CYST

This adverse event was reported 2 times

These drugs are most commonly taken by patients reporting HAEMORRHAGIC PANCREATIC CYST:

# Drug Count
0 CAPLACIZUMAB 1
1 DOCETAXEL 1
2 DOCETAXEL ANHYDROUS 1
3 ENOXAPARIN SODIUM 1
4 RAMUCIRUMAB 1
See all common drugs associated with HAEMORRHAGIC PANCREATIC CYST

HAEMORRHAGIC PANCREATIC CYST is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CAPLACIZUMAB 1 0.0006
1 RAMUCIRUMAB 1 0.0002
2 ENOXAPARIN SODIUM 1 0.0000
3 DOCETAXEL 1 0.0000
4 DOCETAXEL ANHYDROUS 1 0.0000
See all drugs enriched for association with HAEMORRHAGIC PANCREATIC CYST

These drug classes are most commonly taken by patients reporting HAEMORRHAGIC PANCREATIC CYST:

# Drug class Count
0 Microtubule Inhibitor [EPC] 1
1 Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] 1
See all common drug classes associated with HAEMORRHAGIC PANCREATIC CYST

HAEMORRHAGIC PANCREATIC CYST is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] 1 0.0002
1 Microtubule Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with HAEMORRHAGIC PANCREATIC CYST